INTELLION
DEAD

Serial Number

97164075

Owner

VERACYTE DIAGNOSTICS, LLC

Attorney

ROSALEEN H. CHOU

Filing Date

Dec 9, 2021

Add to watchlist:

No watchlists yet
View on USPTO

INTELLION Trademark

Serial Number: 97164075

INTELLION is a trademark filed by VERACYTE DIAGNOSTICS, LLC on December 9, 2021. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

VERACYTE DIAGNOSTICS, LLC (6 trademarks)

180 Varick Street, 6th Floor
New York, NY 10014

Entity Type: 16

C2i Genomics, Inc. (7 trademarks)

New York, NY 10014

Entity Type: 03

Trademark Details

Filing Date

December 9, 2021

Registration Date

Not Registered

Published for Opposition

October 25, 2022

Goods & Services

Genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; medical testing and diagnostic services, namely, diagnostic testing, monitoring, tracking, and reporting for detecting minimal residual disease (MRD) by analyzing, testing, tracking, and reporting DNA, genomes, genotype, and genetic mutations using whole genome pattern recognition, low-input liquid blood biopsy, aggregated SNC and CNV signals, and tracking tumor progression as it evolves during the patient treatment and follow up period

Software-as-a-Service (SaaS) services featuring non-downloadable computer software and Platform-as-a-Service (PaaS) non-downloadable computer software services featuring computer software platforms in the nature of non-downloadable computer software, non-downloadable computer applications, and web-based software, all for accessing cloud-based servers and remote client servers for measuring pre and post-surgical cancer, medical, and disease burden scores through bioinformatics and artificial intelligence, analyzing, testing, tracking, and reporting genetic patterns post-pre- and surgery, providing cancer, medical, and disease treatment recommendation, providing high precision personalized cancer, medical, and disease treatment monitoring throughout the patient cancer, medical, and disease encounter, reducing cancer, medical, and disease treatment costs, and accelerated cancer, medical, and disease drug development for use by pharmaceutical companies and laboratories, health systems, oncologists, physicians, cancer clinics, medical professionals, hospitals, and patients

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 18, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 18, 2024 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 6, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 6, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 6, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 6, 2024 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 11, 2024 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 8, 2024 EXRA
SOU EXTENSION 2 GRANTED
Mar 7, 2024 EX2G
SOU EXTENSION 2 FILED
Mar 7, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 7, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 11, 2023 EXRA
SOU EXTENSION 1 GRANTED
Oct 9, 2023 EX1G
SOU EXTENSION 1 FILED
Oct 9, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 9, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 18, 2023 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 5, 2023 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Nov 21, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 17, 2022 CNSA
ASSIGNED TO EXAMINER
Sep 17, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 14, 2021 NWOS
NEW APPLICATION ENTERED
Dec 13, 2021 NWAP